TY - JOUR
T1 - Irritable bowel syndrome subtype screening characteristics
T2 - Constipation subtype patient profiles explored
AU - Anastasi, Joyce K.
AU - Capili, Bernadette
AU - Quinn, Jessica
AU - McMahon, Donald J.
AU - Scully, Colin
PY - 2012
Y1 - 2012
N2 - Irritable bowel syndrome (IBS), a chronic disorder, greatly impacts the lives of those affected. Approximately one quarter of the North American population suffers from this condition that includes abdominal pain, discomfort and alterations in normal bowel function. Constipation-subtype IBS (IBS-C) is often found to be a prevalent subtype; however, a lack of knowledge and effective treatment options remains surrounding this disorder. In the course of an ongoing study conducted by our research team on the use of acupuncture and moxibustion in the management of IBS symptoms, a considerable number of screened patients have met the widely accepted Rome III criteria for IBS-C.
AB - Irritable bowel syndrome (IBS), a chronic disorder, greatly impacts the lives of those affected. Approximately one quarter of the North American population suffers from this condition that includes abdominal pain, discomfort and alterations in normal bowel function. Constipation-subtype IBS (IBS-C) is often found to be a prevalent subtype; however, a lack of knowledge and effective treatment options remains surrounding this disorder. In the course of an ongoing study conducted by our research team on the use of acupuncture and moxibustion in the management of IBS symptoms, a considerable number of screened patients have met the widely accepted Rome III criteria for IBS-C.
KW - Acupuncture
KW - Complementary and alternative medicine
KW - IBS subtype constipation
KW - Irritable bowel syndrome
KW - Traditional Chinese medicine
UR - http://www.scopus.com/inward/record.url?scp=84864357483&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84864357483&partnerID=8YFLogxK
U2 - 10.4081/gi.2012.e16
DO - 10.4081/gi.2012.e16
M3 - Article
AN - SCOPUS:84864357483
SN - 2036-7422
VL - 4
SP - 69
EP - 72
JO - Gastroenterology Insights
JF - Gastroenterology Insights
IS - 2
M1 - e16
ER -